- |||||||||| Trial completion: Copeptin in Childhood Epilepsy (clinicaltrials.gov) - Sep 19, 2017
P=N/A, N=340, Completed, Active, not recruiting --> Completed
- |||||||||| Trial primary completion date: Copeptin in Childhood Epilepsy (clinicaltrials.gov) - Jan 24, 2017
P=N/A, N=340, Active, not recruiting, Active, not recruiting --> Completed Trial primary completion date: Dec 2016 --> Dec 2015
- |||||||||| Enrollment closed, Trial primary completion date: Copeptin in Childhood Epilepsy (clinicaltrials.gov) - Jul 15, 2016
P=N/A, N=340, Active, not recruiting, Trial primary completion date: Dec 2016 --> Dec 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2016
- |||||||||| Trial primary completion date: Copeptin in Childhood Epilepsy (clinicaltrials.gov) - Nov 25, 2015
P=N/A, N=350, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2016 Trial primary completion date: Oct 2015 --> Jun 2016
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures (clinicaltrials.gov) - Aug 12, 2015
P2/3, N=96, Terminated, Active, not recruiting --> Completed | N=300 --> 122 | Trial primary completion date: Dec 2013 --> Mar 2015 N=288 --> 96 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Jun 2015; results of interim analysis (not safety relevant)
- |||||||||| Trial primary completion date: Copeptin in Childhood Epilepsy (clinicaltrials.gov) - Mar 10, 2015
P=N/A, N=350, Recruiting, N=288 --> 96 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Jun 2015; results of interim analysis (not safety relevant) Trial primary completion date: Mar 2014 --> Oct 2015
|